Simona Landonio

1.6k total citations
32 papers, 776 citations indexed

About

Simona Landonio is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Simona Landonio has authored 32 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 18 papers in Virology and 14 papers in Emergency Medicine. Recurrent topics in Simona Landonio's work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (18 papers) and HIV-related health complications and treatments (14 papers). Simona Landonio is often cited by papers focused on HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (18 papers) and HIV-related health complications and treatments (14 papers). Simona Landonio collaborates with scholars based in Italy, United States and South Africa. Simona Landonio's co-authors include Tiziana Quirino, Paola Meraviglia, Paolo Bonfanti, Ivano Faggion, Silvia Carradori, Luigi Pusterla, Dario Cattaneo, Cristina Gervasoni, Elena Ricci and Fabio Parazzini and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Simona Landonio

31 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simona Landonio Italy	17	615	335	256	203	107	32	776
Paola Cicconi Italy	17	489 0.8×	369 1.1×	301 1.2×	351 1.7×	130 1.2×	45	881
Michael Sension United States	17	1.0k 1.6×	824 2.5×	455 1.8×	123 0.6×	49 0.5×	34	1.2k
Catherine Granier United Kingdom	8	908 1.5×	699 2.1×	267 1.0×	141 0.7×	45 0.4×	10	976
Jennifer S Fusco United States	14	628 1.0×	378 1.1×	330 1.3×	195 1.0×	52 0.5×	57	843
J Gerstoft Denmark	9	314 0.5×	217 0.6×	352 1.4×	104 0.5×	30 0.3×	19	544
Amy Cutrell United States	13	752 1.2×	581 1.7×	223 0.9×	227 1.1×	37 0.3×	18	1.1k
Marek Beniowski Poland	13	690 1.1×	272 0.8×	429 1.7×	288 1.4×	108 1.0×	32	890
Cynthia Brinson United States	18	1.3k 2.2×	1.0k 3.0×	449 1.8×	333 1.6×	118 1.1×	36	1.5k
Lloyd Curtis United States	8	358 0.6×	285 0.9×	206 0.8×	79 0.4×	40 0.4×	12	498
Inmaculada Jiménez‐Nácher Spain	18	759 1.2×	461 1.4×	185 0.7×	304 1.5×	299 2.8×	27	992

Countries citing papers authored by Simona Landonio

Since Specialization

Citations

This map shows the geographic impact of Simona Landonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Landonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Landonio more than expected).

Fields of papers citing papers by Simona Landonio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Landonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Landonio. The network helps show where Simona Landonio may publish in the future.

Co-authorship network of co-authors of Simona Landonio

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Landonio. A scholar is included among the top collaborators of Simona Landonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Landonio. Simona Landonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Mariani, Chiara, Matteo Passerini, Lucia Galli, et al.. (2025). Proactive Therapeutic Drug MONiToring to Guide Suppressive Antibiotic Therapy with DALBAvaNcin ( > 12 weeks) in Osteoarticular Infections (MONTALBANO). Journal of Bone and Joint Infection. 10(4). 255–263.

2.

Rimoldi, Sara Giordana, Cristina Pagani, Alberto Rizzo, et al.. (2023). Traditional Cultures versus Next Generation Sequencing for Suspected Orthopedic Infection: Experience Gained from a Reference Centre. Antibiotics. 12(11). 1588–1588. 4 indexed citations

3.

Capetti, Amedeo, Laura Carenzi, Fosca Niero, et al.. (2017). Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs. Medicine. 96(7). e5728–e5728. 3 indexed citations

4.

Lombardi, Andrea, Simona Landonio, C. Magni, et al.. (2015). ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors. Pharmacology. 96(3-4). 163–166. 1 indexed citations

5.

Gervasoni, Cristina, Paola Meraviglia, Davide Minisci, et al.. (2015). Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?. PLoS ONE. 10(4). e0123670–e0123670. 22 indexed citations

6.

Cattaneo, Dario, Maria Vittoria Cossu, Serena Fucile, et al.. (2014). Comparison of the Pharmacokinetics of Raltegravir Given at 2 Doses of 400 mg by Swallowing Versus One Dose of 800 mg by Chewing in Healthy Volunteers. Therapeutic Drug Monitoring. 37(1). 119–125. 1 indexed citations

7.

Gervasoni, Cristina, Paola Meraviglia, Simona Landonio, et al.. (2013). Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse Events. PLoS ONE. 8(12). e80242–e80242. 36 indexed citations

8.

Cento, Valeria, Simona Landonio, Francesca De Luca, et al.. (2013). A Boceprevir Failure in a Patient Infected with HCV Genotype 1G: Importance and Limitations of Virus Genotyping Prior to HCV Protease-Inhibitor-Based Therapy. Antiviral Therapy. 18(4). 1–5. 14 indexed citations

9.

Gervasoni, Cristina, Paola Meraviglia, Simona Landonio, et al.. (2013). Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected women. Journal of Antimicrobial Chemotherapy. 68(5). 1206–1207. 7 indexed citations

10.

Cattaneo, Dario, Diego Ripamonti, Cristina Gervasoni, et al.. (2011). Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV‐Infected Patients. The Journal of Clinical Pharmacology. 52(3). 440–445. 15 indexed citations

11.

Madeddu, Giordano, Paolo Bonfanti, Giuseppe Vittorio De Socio, et al.. (2007). Tenofovir renal safety in HIV-infected patients: Results from the SCOLTA Project. Biomedicine & Pharmacotherapy. 62(1). 6–11. 52 indexed citations

12.

Bongiovanni, Marco, Teresa Bini, Paola Cicconi, et al.. (2006). Predictive Factors of Hyperlipidemia in HIV-Infected Subjects Receiving Lopinavir/Ritonavir. AIDS Research and Human Retroviruses. 22(2). 132–138. 13 indexed citations

13.

Bongiovanni, Marco, Paola Cicconi, Simona Landonio, et al.. (2005). Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals. International Journal of Antimicrobial Agents. 26(1). 88–91. 29 indexed citations

14.

Meraviglia, Paola, Monica Schiavini, Antonella Castagna, et al.. (2004). Lopinavir/ritonavir treatment in HIV antiretroviral‐experienced patients: evaluation of risk factors for liver enzyme elevation. HIV Medicine. 5(5). 334–343. 42 indexed citations

15.

Bonfanti, Paolo, Elena Ricci, Laura Valsecchi, et al.. (2003). Risk factors for lipodystrophy in the CISAI cohort. Biomedicine & Pharmacotherapy. 57(9). 422–427. 16 indexed citations

16.

Bonfanti, Paolo, Elena Ricci, Simona Landonio, et al.. (2001). Predictors of protease inhibitor-associated adverse events. Biomedicine & Pharmacotherapy. 55(6). 321–323. 14 indexed citations

17.

Quirino, Tiziana, Fosca Niero, Elena Ricci, et al.. (2000). Haart Tolerability: Post-Exposure Prophylaxis in Healthcare Workers versus Treatment in HIV-Infected Patients. Antiviral Therapy. 5(3). 195–197. 25 indexed citations

18.

Bonfanti, Paolo, Laura Valsecchi, Fabio Parazzini, et al.. (2000). Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3). 236–245. 97 indexed citations

19.

Bonfanti, Paolo, Luigi Pusterla, Fabio Parazzini, et al.. (2000). The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. Biomedicine & Pharmacotherapy. 54(1). 45–49. 28 indexed citations

20.

Bonfanti, Paolo, Laura Valsecchi, Fabio Parazzini, et al.. (2000). Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(3). 236–245. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact